Sphera Funds Management’s MediciNova MNOV Stock Holding History

Sphera Funds Management’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-630,838	Closed	-$6.45M	–	116
2018 Q1	$6.45M	Buy	+630,838	New	+$6.29M	0.98%	29

Other funds holding MNOV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Sphera Funds Management's MNOV Position: Q2 2018 in Review

Sphera Funds Management sold out of MediciNova (MNOV) in Q2 2018, closing a stake of 630,838 shares — an estimated $6.45M sold.

Sphera Funds Management first reported a position in MNOV in Q1 2018 and held it in 1 quarter. The position peaked at $6.45M in Q1 2018. 55 funds tracked by Wall St. Rank hold MNOV as of Q2 2018.

Sphera Funds Management reported no remaining MediciNova position as of Q2 2018 after selling out during the quarter.
Sphera Funds Management sold 630,838 MediciNova shares in Q2 2018, an estimated $6.45M.
Sphera Funds Management first reported a position in MediciNova in Q1 2018 and held it in 1 quarter.
Sphera Funds Management's MediciNova position peaked at $6.45M in Q1 2018.
55 funds tracked by Wall St. Rank held MediciNova as of Q2 2018.

Based on Sphera Funds Management's 13F filing for Q2 2018, filed 13 Aug 2018.